# Madrona Venture Group, LLC

> Institutional holdings reported to the SEC as of Q4 2025 on Form 13F. CIK 1887785. Source: https://holderbook.com/funds/1887785-madrona-venture-group-llc/

- Reported value: $22.1M
- Positions: 3
- Weight of the ten largest: 100.0%
- Filed: 2026-02-13

A 13F reports long US equity positions only. Short positions, bonds, foreign listings, private holdings and cash are not visible, so this is not the manager's whole book.

## Holdings

| Security | Ticker | Value | Shares | Weight | Quarters held |
|---|---|---|---|---|---|
| NAUTILUS BIOTECHNOLOGY INC | [NAUT](https://holderbook.com/stocks/NAUT/) | $11.7M | 6,020,770 | 53.2% | 19 |
| UIPATH INC | [PATH](https://holderbook.com/stocks/PATH/) | $10.0M | 607,673 | 45.2% | 19 |
| GINKGO BIOWORKS HOLDINGS INC | [DNA](https://holderbook.com/stocks/DNA/) | $353.0K | 42,430 | 1.6% | 3 |

## What the disclosed book did

Not the fund's return. This is the change in value of the positions disclosed on Form 13F, had they been left untouched, against SPY over the same quarter ends.

| Quarter | Book | Market | Difference | Priced |
|---|---|---|---|---|
| Q4 2023 | +53.1% | +11.2% | +41.9% | 100% |
| Q3 2023 | +6.2% | -3.6% | +9.8% | 100% |
| Q2 2023 | +12.1% | +8.3% | +3.9% | 100% |
| Q1 2023 | +18.7% | +7.0% | +11.7% | 100% |
| Q4 2022 | -4.5% | +7.1% | -11.6% | 100% |
| Q3 2022 | +0.9% | -5.3% | +6.2% | 100% |
| Q2 2022 | -36.2% | -16.5% | -19.7% | 100% |

## Quarter by quarter

| Quarter | Value | Positions |
|---|---|---|
| Q4 2025 | $22.1M | 3 |
| Q3 2025 | $13.8M | 3 |
| Q2 2025 | $12.6M | 3 |
| Q1 2025 | $28.5M | 3 |
| Q4 2024 | $53.8M | 4 |
| Q3 2024 | $74.6M | 4 |
| Q2 2024 | $93.7M | 4 |
| Q1 2024 | $117.5M | 4 |
| Q4 2023 | $427.1M | 6 |
| Q3 2023 | $291.9M | 6 |
| Q2 2023 | $274.6M | 5 |
| Q1 2023 | $246.7M | 6 |